August 25, 2010
Cancer is the second leading cause of death in the United States. More than 1.5 million new cancer cases will be diagnosed during 2010. To help oncology medical professionals stay abreast of emerging trends and cancer care, Midwest Cancer Care is sponsoring its 2010 Oncology Symposium. Distinguished faculty from the Cleveland Clinic Taussig Cancer Institute, Brigham and Women’s Hospital, Sarah Cannon Research Institute and Midwest Cancer Care will lead the discussions and sessions from 10 a.m. to 4:15 p.m. on Friday, Sept. 24, at the Sheraton Overland Park in Overland Park, Kansas.
Primary care physicians, surgeons, medical oncologists, radiation oncologists, physician assistants, oncology nurses and other healthcare professionals involved in the care of the patient with cancer are encouraged to attend this informative one-day conference. CME and CEU credits are available.
Midwest Cancer Care, part of HCA Midwest Health System—Kansas City’s largest healthcare network—includes hospitals in Kansas and Missouri anchored by the accredited cancer care programs at Centerpoint Medical Center, Menorah Medical Center and Research Medical Center.
Symposium topics include updates in the areas of screening; diagnosis and care of breast cancer; implications of new diagnostic tools; expanding therapy options and survivorship issues in the care of the cancer patient; systematic therapies used to treat metastatic renal cancer; the use of targeted radiotherapy in low grade B cell lymphoma and malignant melanoma; and review of new agents in the management of low grade lymphoma and their evaluation in clinical trials.
Simon Abrahms, vice president of Midwest Cancer Care, says the 2010 Oncology Symposium is a unique meeting for the Kansas City region oncology community. “The symposium is devoted to providing educational sessions that highlight new approaches to cancer management,” says Abrahms. “It’s an exceptional opportunity for physicians and nursing professionals to learn about leading scientific research from some of the country’s and region’s best cancer researchers, academicians and surgeons.”
John Sweetenham, MD, FRCP, and professor of medicine and vice-chair for clinical research at the world-renowned Cleveland Clinic Taussig Cancer Institute will deliver the keynote address. Dr. Sweetenham holds extensive research funding, has published a large body of significant work on hematologic malignancy and lectures worldwide on the management of lymphoma and the use of stem cell transplantation.
Faculty include Howard A. “Skip” Burris III, MD, chief medical officer and director of drug development, Sarah Cannon Research Institute; Shalina Gupta-Burt, MD, dual-certified in oncology and radiation, Midwest Cancer Care Menorah Medical Center; Amie Jew, MD, breast surgeon, Aasha Surgical P.A.; John Sheldon, MD, Midwest Cancer Care at Research Medical Center; Akila N. Viswanathan, MD, MPH, Brigham and Women’s Hospital/Dana-Farber Cancer Institute; Alan Lichtin, MD, Cleveland Clinic Foundation; Roger M. Macklis, MD, Cleveland Clinic Foundation; and Laura Wood, RN, MSn, OCN, Cleveland Clinic Foundation.
Menorah Medical Center is accredited by the Kansas Medical Society and the Kansas State Board of Nursing to provide continuing medical education for physicians and nurses. Menorah Medical Center designates this educational activity for a maximum of four (4) AMA PRA Category 1 CreditsTM. This course offering is approved for 4.0 contact hours for RN or LPN relicensure.